# Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy

> **NCT05676866** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 30 (estimated)

## Conditions studied

- Node-positive Breast Cancer

## Interventions

- **PROCEDURE:** Targeted axillary lymph node dissection

## Key facts

- **NCT ID:** NCT05676866
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05676866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05676866, "Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05676866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*